Delivery Order SPE2DB20D3104-SPE2DB23FV8Z6

Award Date 9/13/23
Potential Completion Date 10/4/23
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.25 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through March 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,221.00 firm fixed-price delivery order covers the provision of RHOGAM ULTRA-FILTERED PLUS SYRS, a critical medical product, with a performance period through December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a critical medical product. The $4,720.80 firm fixed price delivery order (SPE2DB20D3101|SPE2DB24FRQT0) has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,180.20, is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, and has a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
The federal contract award, with ID SPE2DB20D3103/SPE2DB22FP2V7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,590.90 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with an ultimate completion date of August 12, 2022. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rhogam Ultra-Filtered Plus Syringes. The contract has a ceiling value of $2,360.40 and a performance period that runs through July 3, 2024. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,832.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a completion date of July 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the federal government - one with the DLA Troop Support Medical valued up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.24 delivery order contract is for the supply of Rhogam Ultra-Filtered Plus syringes, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of October 21, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of RHOGAM ULTRA-FILTERED PLUS syringes. The contract was awarded by the Defense Logistics Agency (DLA) and is a Delivery Order with a Firm Fixed Price of $1,652.28 and a Period of Performance ending on November 1, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain to provide a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.36 firm fixed-price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2022 and was awarded on September 28, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV8Z6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,325.28 delivery order contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a period of performance through October 4, 2023.

The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

These contracting vehicles enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:21 AM